Genomics and Public Health in the United States: Signposts on the Translation Highway

Successful completion of the Human Genome Project has raised public expectations that research findings will translate quickly into health benefits; however, the gap between biomedical research and clinical and public health application seems wider than ever. Public health scientists now have the opportunity to help create a broad concept of research translation that integrates genomic information into policies, programs and sevices benefiting the whole population. Important ’signposts’ along the translation highway include conducting population-based reearch in genomics, developing evidence on the clinical and public health value of genomic information, and integrating genomics into health practice.

[1]  F. Collins,et al.  A vision for the future of genomics research , 2003, Nature.

[2]  H Campbell,et al.  Gene–environment interactions—the BioBank UK study , 2002, The Pharmacogenomics Journal.

[3]  C. Lenfant.  Shattuck lecture--clinical research to clinical practice--lost in translation? , 2003, The New England journal of medicine.

[4]  Aric Invest.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[5]  Muin J Khoury,et al.  Research priorities for evaluating family history in the prevention of common chronic diseases. , 2003, American journal of preventive medicine.

[6]  Newborn.  Use of Inhaled Nitric Oxide , 2000, Pediatrics.

[7]  V A McKusick,et al.  Genomics and medicine. Dissecting human disease in the postgenomic era. , 2001, Science.

[8]  M. Khoury,et al.  Genomic profiling to promote a healthy lifestyle: not ready for prime time , 2003, Nature Genetics.

[9]  U. P. S. T. Force.  Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement , 2005, Annals of Internal Medicine.

[10]  F. Collins,et al.  Implications of the Human Genome Project for medical science. , 2001, JAMA.

[11]  I. Kawachi,et al.  Individual risk prediction and population-wide disease prevention. , 2000, Epidemiologic reviews.

[12]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[13]  Kari Stefansson,et al.  deCODE genetics, Inc. , 2003, Pharmacogenomics.

[14]  Walter C Willett,et al.  Balancing Life-Style and Genomics Research for Disease Prevention , 2002, Science.

[15]  Leena Peltonen,et al.  Dissecting Human Disease in the Postgenomic Era , 2001, Science.

[16]  L. Bierut,et al.  Setting Priorities for Genomic Research , 2004, Science.

[17]  Illinois.,et al.  Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs , 2000, Pediatrics.

[18]  Sholom Wacholder,et al.  One gene and one outcome? No way. , 2002, Trends in molecular medicine.

[19]  Francis S. Collins,et al.  The case for a US prospective cohort study of genes and environment , 2004, Nature.

[20]  Muin J Khoury,et al.  The emergence of epidemiology in the genomics age. , 2004, International journal of epidemiology.

[21]  N. Risch,et al.  Genomic Priorities and Public Health , 2003, Science.

[22]  W. Burke,et al.  Genetic Testing , 2019, Definitions.

[23]  Tracy A Wolff,et al.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. , 2006, American family physician.